FDA Investigator Megan E Kulas
Megan E Kulas has conducted inspections on 55 sites in 5 countries as of 16 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
16 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Poland,
Ireland,
Germany,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Megan E Kulas:
Abigail A Andersen,
Adam S Freeman,
Alexandra M Cossi,
Alexis R Ajello,
Alison A Nicoli,
Andrew B Slarve,
Andrew E Kay,
Andrew F Cohen,
Andrew T Todd,
Angel K Sandhu,
Anna J Vickrey,
Annemarie Kleiza,
Barbara J Arrais,
Breena L D'ambrogi,
Brian P Hendrickson,
Brian R Henderson,
Brian R Yaun,
Brian Ravitch,
Bruce D Broidy,
Capri R Woolridge,
Carl Lee,
Cary Greene,
Catherine D Djordjevic,
Celeste K Wong,
Chloe Anne Leong,
Christian L Witkovskie,
Christine M Parmentier,
Courtney R Bolton,
Craig K Hopkins,
Craig P Seaborn,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Dariusz Galezowski,
Darren S Morgan,
David A Lum,
David G Whitman,
Deborah K Richardson,
Dell S Moller,
Dennis L Doupnik,
Desiree C Iya,
Diane R Mcdaniel,
Dustin R Abaonza,
Edna J Hidalgo,
Edward O'shaughnessy,
Elaine S Chow,
Elizabeth P Mayer,
Emal Wahab,
Eric J Heinze,
Eric Rothschild,
Erica L Nicoll,
Erica R Mahone,
Erica R Pomeroy,
Estefania Fernandez,
Evan M Kupper,
Frank P Bianco,
Gillenwater,
Glen E Harelson,
Greg K Keshishyan,
Gulshan R Anand,
Hanna S Louvau,
Huy T Pham,
James C Lee, PharmD,
James C Yee,
Jane C Chen,
Jane G Choi,
Janice R Small,
Janice Wai,
Javonica F Penn,
Jeanmaire Hryshko,
Jeanne A Young,
Jennifer M Heitz,
Jennifer S King,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
John Cook,
John M Seale,
Jolene S Hedgecock,
Joseph A Seitz, III,
Juan A Morales,
Kacie M Crowther,
Karen J Bak,
Karen M Labounty,
Karla J Gibler,
Kathleen J Close,
Katie T Duong,
Kawshalya Pathiraja,
Kelli A Giannattasio,
Kelli L Wilkinson,
Keren Arkin,
Kirk A Dymbrowski,
Kristin M Abaonza,
Larkin R Buckalew,
Larry K Austin,
LCDR Jennifer H Rhyu,
Leslie R Clark,
Lija V Fellows,
Lisa H Nakagawa,
Lorraine N Williams,
Lucila B Nwatu,
Lydia S Chan,
Lynn L Wong,
Mabel M Lee,
Maida Henesian (NMI),
Maridali Deleon Torres,
Mark I Nakano,
Mark L Collins,
Mary C Acton,
Matt D Suedkamp,
Matthew K Wong,
Mcgrewp,
Megan E Kerry,
Mei Chiung Huang (Jo),
Melissa B Libby,
Melissa N Simanton,
Melody M Ragasa Leong,
Melvin Dorin,
Meredith P Soehl, Investigator,
Michael A Feingold,
Michael E Campbell,
Michael K Larson,
Michael L Myers,
Nianna C Burns,
Nicole Yuen,
Nympha V Florendo,
Patrick E Gainer,
Paula E Davis Debella,
Pedro A Cruz,
Peter E Baker,
Phillip M Pontikos,
Phung,
Quynh H Strandberg,
Randall J Plunkett,
Rashonda N Rucker,
Raymond M Lam,
Rene M Amaguana,
Riley C Graham,
Robert P Neligan,
Robert W Calais,
Roger D Gawne,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sabino S Camacho,
Sara M Richardson,
Savannah E Samp,
Sergio Chavez (NMI),
Seyra Z Hammond,
Seyyida Saterfield,
Sherri J Jackson,
Siobhan A Gallagher,
Sonia D Hudson,
Steve P Yost,
Steven B Chiu,
Steven J Branch,
Steven M Galvez,
Stuart Kim,
Stuart W Russell,
Susan M Taylor,
Thomas J Prigge,
Thomas N Adjabeng,
Thomas W Nerney,
Travelle D Mason,
Tressa T Lewis,
Vi T Au,
Wen Jun Peng,
William J Foust,
William J Weis,
William V Millar,
Yen Tso Kuo,
Zachary Ryan Harris
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more